I haven’t read the separate statements of the individual FTC members yet. My hope: The FTC investigation includes pricing of insulin—the most expensive medication in terms of co-pay that I will be taking for the rest of my life. If there has been follow-up of recent pharm executive testimony with respect to insulin prices before Congress by any regulatory authority in the United States government, I have missed it.